Overman Larry E, Rhee Young Ho
Contribution from the Department of Chemistry, 516 Rowland Hall, University of California-Irvine, Irvine, CA 92697-2025, USA.
J Am Chem Soc. 2005 Nov 9;127(44):15652-8. doi: 10.1021/ja055464h.
Total syntheses of the 3S,8S,10S,19R,43S isomer 4a and the 3S,8S,10S,19R,43R isomer 4b of the unique crambescidin alkaloid crambidine are reported. These studies confirm the tetracyclic structure proposed by Braekman and co-workers for crambidine, and establish the rel-3R,8R,10R,19S relative configuration for this moiety. Natural crambidine is most likely the 3S,8S,10S,19R,43S isomer 4a. These syntheses were completed in five steps and approximately 14% overall yield from 1-iminohexahydro[1,2-c]pyrimidine carboxylic ester 10, an intermediate in our earlier total synthesis of 13,14,15-isocrambescidin 800 (3). The signature step in the total syntheses of crambidine and several stereoisomers is chemoselective dehydrogenation of the tethered Biginelli adduct 10 or the derived tetracyclic intermediate 17. Additionally, these studies reveal the unprecedented ring-chain isomerization of the crambidine ring system exemplified by the interconversion of isomers 15a and 15b.
报道了独特的克拉米松生物碱克拉米定的3S,8S,10S,19R,43S异构体4a和3S,8S,10S,19R,43R异构体4b的全合成。这些研究证实了布拉克曼及其同事提出的克拉米定的四环结构,并确定了该部分的rel-3R,8R,10R,19S相对构型。天然克拉米定很可能是3S,8S,10S,19R,43S异构体4a。这些合成以五步完成,从1-亚氨基六氢[1,2-c]嘧啶羧酸酯10开始,总产率约为14%,10是我们早期全合成13,14,15-异克拉米松800(3)中的中间体。克拉米定和几种立体异构体全合成中的标志性步骤是连接的Biginelli加合物10或衍生的四环中间体17的化学选择性脱氢。此外,这些研究揭示了克拉米定环系统前所未有的环链异构化,以异构体15a和15b的相互转化为例。